Cancer Treatment by Country

Israel

Innovation hub for cancer research and biotechnology, with strong CAR-T and immunotherapy clinical trial activity.

Japan

Pioneer in heavy ion therapy and proton therapy. Leading research in immuno-oncology and precision medicine.

Malaysia

Spain

Thailand

Established medical tourism destination with internationally accredited hospitals offering surgical oncology, radiation, and proton therapy.

United Arab Emirates

India

Leading destination for affordable, high-quality cancer care. Home to JCI-accredited hospitals, advanced bone marrow transplant programs, and India's first CAR-T therapy (NexCAR19/Actalycabtagene autoleucel).

China

Global leader in cell and gene therapy clinical trials, with the world's largest CAR-T trial pipeline including solid tumor CAR-Ts (Claudin 18.2, GPC3, CEA, GD2). Home to first-approved gene therapy (Gendicine) and major proton/heavy ion centers.

United States

World leader in oncology research and FDA-approved advanced therapies. Home to NCI-designated Comprehensive Cancer Centers and the largest pipeline of approved cell, gene, and targeted therapies.

Singapore

Premium oncology destination in Asia with internationally accredited hospitals, English-language care, and proton therapy availability.

South Korea

Advanced oncology infrastructure with strong programs in proton therapy, robotic surgery, and stem cell transplantation.

Germany

European oncology leader with advanced proton, heavy ion, and CAR-T programs at university hospitals and dedicated cancer centers.

United Kingdom

Turkey

Growing oncology destination with cost-effective access to advanced treatments including bone marrow transplant and proton therapy.